← All news

FROM THE NEWS FEED

Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

2026-08-06 • Psychedelic Invest

Article summary

NEW YORK, August 06, 2026--Definium Therapeutics, Inc. ("Definium" or the "Company") (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics…

Continue to the original publication for the complete article.